Genistein Suppresses IL-6 and MMP-13 to Attenuate Osteoarthritis in Obese Diabetic Mice
Type 2 diabetes mellitus and osteoarthritis (OA) often present as comorbidities. We examined the role of plasma IL-6, chondrocyte MMP-13, and col10a expression in the development of OA in obese diabetic mice. We further investigated dietary genistein and exercise training as potential mitigators of...
Main Authors: | Janelle Lopez, Layla Al-Nakkash, Tom L. Broderick, Monica Castro, Brielle Tobin, Jeffrey H. Plochocki |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-09-01
|
Series: | Metabolites |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-1989/13/9/1014 |
Similar Items
-
Genistein treatment increases bone mass in obese, hyperglycemic mice
by: Michelin RM, et al.
Published: (2016-03-01) -
The protective activity of genistein against bone and cartilage diseases
by: Zhenyu Wu, et al.
Published: (2022-09-01) -
Self-assembled genistein nanoparticles suppress the epithelial-mesenchymal transition in glioblastoma by targeting MMP9
by: Qingyu Zhao, et al.
Published: (2025-04-01) -
Dietary Genistein Rescues Reduced Basal Chloride Secretion in Diabetic Jejunum via Sex-Dependent Mechanisms
by: Shawn Catmull, et al.
Published: (2016-11-01) -
Genistein - characterization of the molecule, similarity to estradiol and pharmacological potential
by: Kacper Kossakowski, et al.
Published: (2023-06-01)